The core risk is conversion, not demand. AV must turn
backlog, Army pathway wins, and new capacity into repeat deliveries and margin recovery while digesting
BlueHalo. If
SCAR-style resets recur or factories outrun funded demand, the stock can lose its defense-tech premium quickly.